FindTrial
Sign In

evaluation of change in swallowing function and dietary pattern for patients of head and neck cancer undergoing Intensity Modulated Radiotherapy

Prospective subjective evaluation of change in swallowing function and dietary pattern using performance status scale for head and neck cancer (PSS-HN) scale for patients of head and neck cancer undergoing curative intent Intensity Modulated Radiotherapy with or without chemotherapy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2017/11/010378
Enrollment
60
Registered
2017-11-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Fit for curative intent Radiation / chemoradiation Health Condition 2: C00-C14- Malignant neoplasms of lip, oral cavity and pharynx

Interventions

None listed

Sponsors

Jaslok Hospital and Research Center
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age more than 18 years No prior radiation to head and neck area Histology squamous cell carcinoma written informed consent Performance status 0/1 Willing for follow up All head and neck cancers except para nasal sinuses T1-T4, N0-N3, M0

Exclusion criteria

Exclusion criteria: Prior Radiation to Head and neck area Pre existing swallowing dysfunction not related to cancer Non squamous histology

Design outcomes

Primary

MeasureTime frame
To assess change in subjective swallowing score using PSS-HN for head neck carcinoma patient undergoing curative intent radiation with IMRT during 6 months post radiotherapy as compared to pre-radiotherapy.Timepoint: Baseline, at Radiation Completion, at 3 months post radition, at 6 months post radiation—

Secondary

MeasureTime frame
1. Identifying the Patient and tumour factors influencing PSS-HN scores 2. To determine the Correlation between PSS HN Score and doses to Dysphagia / Aspiration at risk structures (DARS) 3. Calculating the Disease Free survival at 1 and 2 years Timepoint: 6 months—

Countries

India

Contacts

Public ContactDr Sharmila Agarwal

Jaslok Hospital and Research Center

nikhil.kalyani@yahoo.com7977022499

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026